aspirin has been researched along with Brain Injury, Vascular in 5 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Excerpt | Relevance | Reference |
---|---|---|
"The majority of traumatic aneurysms can be managed with an antiplatelet regimen of 325 mg aspirin daily and serial imaging." | 3.80 | Extracranial traumatic aneurysms due to blunt cerebrovascular injury. ( Falola, M; Foreman, PM; Griessenauer, CJ; Harrigan, MR, 2014) |
"Although acute stroke is also relatively common in this population, two thirds of strokes are already evident on admission." | 1.72 | Imaging analysis of ischemic strokes due to blunt cerebrovascular injury. ( Abraham, MN; Abraham, PJ; Black, JA; Griffin, RL; Harrigan, MR; Holcomb, JB; Jansen, JO; Kerby, JD; Liptrap, EJ; Thaci, B, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, PJ | 1 |
Black, JA | 1 |
Griffin, RL | 1 |
Abraham, MN | 1 |
Liptrap, EJ | 1 |
Thaci, B | 1 |
Holcomb, JB | 1 |
Kerby, JD | 1 |
Harrigan, MR | 2 |
Jansen, JO | 1 |
Catapano, JS | 1 |
Israr, S | 1 |
Whiting, AC | 1 |
Hussain, OM | 1 |
Snyder, LA | 1 |
Albuquerque, FC | 1 |
Ducruet, AF | 1 |
Nakaji, P | 1 |
Lawton, MT | 1 |
Weinberg, JA | 1 |
Zabramski, JM | 1 |
Paketci, S | 1 |
Hanna, K | 1 |
Khurrum, M | 1 |
Joseph, B | 1 |
Foreman, PM | 1 |
Griessenauer, CJ | 1 |
Falola, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pilot, Non-masked, Randomized Clinical Trial for Evaluation of Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).[NCT05868525] | Phase 4 | 98 participants (Anticipated) | Interventional | 2024-04-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 other studies available for aspirin and Brain Injury, Vascular
Article | Year |
---|---|
Imaging analysis of ischemic strokes due to blunt cerebrovascular injury.
Topics: Aspirin; Cerebrovascular Trauma; Humans; Ischemic Stroke; Retrospective Studies; Stroke; Wounds, Non | 2022 |
Management of Extracranial Blunt Cerebrovascular Injuries: Experience with an Aspirin-Based Approach.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Dissection; Aspirin; Carotid Artery Injuries; Caroti | 2020 |
In response to: Female sex as a risk factor for blunt cerebrovascular injuries and aspirin resistance.
Topics: Anticoagulants; Aspirin; Cerebrovascular Trauma; Female; Humans; Platelet Aggregation Inhibitors; Ri | 2021 |
Authors' reply: Aspirin resistance and blunt cerebrovascular injuries among female patients.
Topics: Anticoagulants; Aspirin; Cerebrovascular Trauma; Female; Humans; Platelet Aggregation Inhibitors; Wo | 2021 |
Extracranial traumatic aneurysms due to blunt cerebrovascular injury.
Topics: Adolescent; Adult; Aneurysm; Aspirin; Cerebral Angiography; Cerebrovascular Trauma; Cohort Studies; | 2014 |